October 26 | 2023 Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation Read more
October 11 | 2023 2cureX advances towards IVD-R compliance by securing a contract with a Notified Body Read more
October 3 | 2023 2cureX will be holding its Q3 2023 online presentation with a Q&A session on October 26, 2023 at 20.00 (CET). Read more
August 30 | 2023 2cureX launches its first two IndiTreat® products CE-marked under the new IVD Regulation Read more
July 5 | 2023 Invitation to 2cureX Q2 update and Q&A session on July 12, 2023 at 20.00 (CET) Read more
June 15 | 2023 2cureX Newsletter. Our colorectal cancer portfolio is on track – Pancreatic cancer is next. Read more